0001213900-14-008789.txt : 20141208 0001213900-14-008789.hdr.sgml : 20141208 20141208165403 ACCESSION NUMBER: 0001213900-14-008789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141204 FILED AS OF DATE: 20141208 DATE AS OF CHANGE: 20141208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Straube Richard CENTRAL INDEX KEY: 0001595197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 141273026 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE, SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 f4120414straube_soligenix.xml OWNERSHIP DOCUMENT X0306 4 2014-12-04 0 0000812796 SOLIGENIX, INC. SNGX 0001595197 Straube Richard 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540 0 1 0 0 Sr VP & Chief Medical Officer Stock Option (Right to Buy) 1.50 2014-12-04 4 A 0 50000 0 A 2014-12-04 2024-12-03 Common Stock 50000 50000 D The stock option vested immediately as to 12,500 shares and vests as to the remainder at a rate of 3,125 shares on each three (3) month anniversary of December 4, 2014. /s/ Richard Straube 2014-12-08